Centene stock gained 3.28 percent as earnings recovery took hold

Published on 10/04/2026 at 17:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Centene stock is priced at USD 62.99 after second-quarter adjusted EPS reached USD 2.51 on June 30, 2026. Analysts put the 12-month average target at USD 71.78.

Luftbild eines modernen Pharma-Lagerzentrums mit Lieferfahrzeugen und Verladedocks — Cencora Inc. betreibt US15135B1017 ein großes Pharmadistributionszentrum mit Lastwagen Gabelstaplern und täglicher Medikamentenlogistik, Illustration mit AI erstellt.

Centene stock (ISIN US15135B1017) gained 3.28 percent and was last at USD 62.99 on the NYSE on October 2, 2026, at 4:02 p.m. ET. The move followed a second-quarter earnings beat and higher full-year guidance reported by Zacks in its analysis of the quarter ended June 30, 2026.

Adjusted EPS reached USD 2.51

Centene reported adjusted EPS of USD 2.51 for Q2 2026, versus a loss of USD 0.16 per share in the prior-year quarter, according to Zacks. Revenue reached USD 53.6 billion, an increase of 9.9 percent year over year, while the health benefits ratio improved 340 basis points to 89.6 percent.

The operating picture was mixed beneath the earnings headline. Total membership fell 7.6 percent year over year to 25.9 million as of June 30, 2026, while Medicare revenue increased 17 percent to USD 11.1 billion and Medicaid revenue rose 5 percent to USD 22.8 billion, the same Zacks report states.

Guidance now starts above USD 4.80

Management raised 2026 total revenue guidance to USD 193.5 billion to USD 197.5 billion from USD 187.5 billion to USD 191.5 billion, while adjusted EPS guidance moved above USD 4.80 from USD 3.40, according to Zacks. The guidance change gives the stock a fundamental anchor after its October 2 advance.

Centene also faces a valuation test. The shares were 9.54 percent below their 52-week high of USD 69.63 on October 2, while the session range ran from USD 60.78 to USD 63.36 and volume reached 3,573,311 shares.

Analysts see USD 71.78 target

The consensus rating is Buy, based on 18 analysts, with an average 12-month price target of USD 71.78, a high of USD 85.00 and a low of USD 56.00, according to Investing.com. The average target lies 13.95 percent above the October 2 price, leaving the market focused on whether margin improvement can offset lower membership.

Centene stock heads toward October 27

Centene stock was last at USD 62.99 on the NYSE on October 2, 2026, while its market capitalization stood at USD 31.1 billion. The next earnings release is scheduled for October 27, 2026.